Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CFHR3 is a potential novel biomarker for hepatocellular carcinoma.

Journal of cellular biochemistry - 1 Apr 2020

Liu Jun, Li Wenli, Zhao Hetong

Abstract excerpt

Complement factor H-related 3 (CFHR3) is a protein-coding gene acting in various diseases. However, its prognostic values of CFHR3 in hepatocellular carcinoma (HCC) are not understandable. Therefore, we present a further study on CFHR3 in HCC. CFHR3 expression data were acquired from The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC). We compared the differential expression of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Blood Proteins
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Neoplasms

Share to Proportional Hazards Models

Share to ROC Curve

Share to Software

Source

Identifiers

PMID: 31709629
DOI: 10.1002/jcb.29551

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CFHR3 is a potential novel biomarker for hepatocellular carcinoma.PMID 31709629Read ↗

Identification of CFHR4 Associated With Poor Prognosis of Hepatocellular CarcinomaSemantic proximity Read ↗

Expressional and prognostic value of CRLF3 in liver hepatocellular carcinoma patients via integrated bioinformatics analyses and experimentsSemantic proximity Read ↗

Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathwaysSemantic proximity Read ↗

Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular CarcinomaSemantic proximity Read ↗

TNNI3 expression and prognostic value and correlation with tumor-infiltrating immune cells in LIHC: A bioinformatics analysisSemantic proximity Read ↗

CENPA and IQGAP3 Identified as Ideal Early-Stage Hepatocellular Carcinoma MarkersSemantic proximity Read ↗

ERCC3 serves as a prognostic biomarker for hepatocellular carcinoma and positively regulates cell proliferation and migrationSemantic proximity Read ↗

FCN3 Is a Prognostic Biomarker Correlated with Immune Response in Liver CancerSemantic proximity Read ↗

CBX3 Is a Prognostic Biomarker That Is Correlated With Lymphocyte Infiltration in Hepatocellular CarcinomaSemantic proximity Read ↗

The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinomaSemantic proximity Read ↗

PDCL3 is a Novel Oncogenic Indicator in Hepatocellular Carcinoma using Comprehensive Bioinformatics Analysis and in vitro ValidationSemantic proximity Read ↗

High Expression of TTYH3 Predicts Poor Outcome in Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.